Pharmacogenomics into clinical practice: development of UK guidelines

Date: Monday 15 June
Time: 2.00pm - 3.15pm

Overview

This session will provide delegates with an overview of the Centre for Excellence in Regulatory Science and Innovation (CERSI) in Pharmacogenomics project, which has a focus on the implementation of pharmacogenomics into the NHS. Pharmacogenomic testing guidelines for Carbamazepine and Clozapine have been developed, with the aims of improving patient outcomes and reducing safety issues.

The session will cover the research evidence base for the guidelines, clinical pathways and health economic analysis of likely cost savings. The role of psychiatrists as key clinicians in the implementation of the guidelines will be discussed. Patient and carer perspectives on the potential benefits of pharmacogenomics testing will be highlighted.

In this session you will explore:

  • In this session the research evidence base that underpins the pharmacogenomic guidelines will be outlined
  • You will understand the key recommendations made in the Carbamazepine and Clozapine pharmacogenomic testing guidelines, and will be aware of the role of psychiatrists in implementing the guidelines
  • The benefits to patients of implementing the pharmacogenomic guidelines, in terms of improved outcomes and reduced adverse events, will be explored

Speakers

  • Chair: Professor Regi Alexander, Hertfordshire Partnership University NHS Foundation Trust, Little Plumstead
  • Mindfulness and medication: expert by experience perspective
    • Dr Mary Ryan, University of Exeter, Exeter
  • UK pharmacogenomic guideline for HLA genotyping with carbamazepine
    • Professor Sir Munir Pirmohamed, David Weatherall Chair of Medicine and NHS Chair of Pharmacogenetics, Liverpool
  • Pharmacogenetics in psychosis
    • Professor Elvira Bramon, University College London, London
  • Engaging people living with psychiatric diagnoses and their families in pharmacogenomic testing implementation
    • Dr David Crepaz-Keay, The Mental Health Foundation, London
    Register for Congress 2026

    Please email congress@rcpsych.ac.uk or call 020 8618 4120 with any enquiries.